Commercial Supply Alogliptin Benzoate (CAS: 850649-62-6) Related Intermediates:
6-Chloro-3-methyluracil CAS: 4318-56-3
2-Cyanobenzyl Bromide CAS: 22115-41-9
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS: 334618-23-4
2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyriMidinyl)Methyl]benzonitrile CAS: 865758-96-9
Commercial Supply Trelagliptin Succinate (CAS: 1029877-94-8) Related Intermediates:
6-Chloro-3-methyluracil CAS: 4318-56-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS: 334618-23-4
2-Cyano-5-Flurobenzyl Bromide CAS: 421552-12-7
| Chemical Name |
(R)-(-)-3-Aminopiperidine Dihydrochloride |
| Synonyms |
(R)-(-)-3-Piperidinamine Dihydrochloride |
| CAS Number |
334618-23-4 |
| CAT Number |
RF-PI140 |
| Stock Status |
In Stock, Production Scale Up to Tons |
| Molecular Formula |
C5H12N2·2HCl |
| Molecular Weight |
173.08 |
| Melting Point |
190.0~195.0℃ |
| Solubility |
Soluble in Water |
| Shipping Condition |
Shipped Under Ambient Temperature |
| Brand |
Ruifu Chemical |
| Item |
Specifications |
| Appearance |
White Solid |
| IR |
Conformed |
| Chemical Purity |
≥99.0% (HPLC) |
| Any Individual Impurity |
≤0.20% |
| Optical Purity |
e.e ≥99.0% |
| Moisture (K.F) |
≤0.50% |
| Residue on Ignition |
≤0.10% |
| Test Standard |
Enterprise Standard |
| Usage |
Intermediate of Linagliptin, Alogliptin, Trelagliptin |
Package: Bottle, Aluminum foil bag, 25kg/Cardboard drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture.
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (R)-(-)-3-Aminopiperidine Dihydrochloride (CAS: 334618-23-4) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and active pharmaceutical ingredient (API) synthesis, suach as Alogliptin Benzoate (CAS: 850649-62-6), Trelagliptin Succinate (CAS: 1029877-94-8), and Linagliptin (CAS 668270-12-0).
Alogliptin Benzoate (CAS: 850649-62-6) is a type-2 diabetes medication, and it is a type of serine protease dipeptidyl peptidase IV (DPP-4) inhibitor. Alogliptin, used alone or in combination with other blood sugar-lowering medication, is usually well-tolerated in type-2 diabetes patients.
Trelagliptin Succinate (CAS: 1029877-94-8) (SYR-472) is a selective, long acting dipeptidyl peptidase-4 (DPP-4) inhibitor used for the treatment of type 2 diabetes mellitus. An antidiabetic agent.Trelagliptin Succinate was approved for use in Japan in March 2015.